Norwegian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Side 1 fra 22 resultater
Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND
Gastroenteritis attributable to viruses or bacteria is a condition that causes irritation and inflammation of the stomach and intestines (the gastrointestinal tract). Other causes include parasites, food allergens, drug reactions to antibiotics, and ingestion of toxic plants. Vomiting
Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
The present invention relates to oral pharmaceutical formulations designed to reduce or eliminate adverse effects of drugs typically associated with side effects such as emesis and diarrhea. In particular, the invention is directed to oral pharmaceutical formulations
Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
The present invention relates to oral pharmaceutical formulations designed to reduce or eliminate adverse effects of drugs typically associated with side effects such as emesis and diarrhea. In particular, the invention is directed to oral pharmaceutical formulations
Treatment of diarrhea
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to therapeutic treatment of infectious gastroenteritis.
2. Description of the Related Art
Normal microflora is important in the protection of the host against diseases of the gastrointestinal (GI) tract (Fuller, R., Gut
Opioid compounds and methods for using same
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter
Opioid compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter
Opioid compounds and methods for making therefor
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter
Method of using a gastrointestinal stimulator device for digestive and eating disorders
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
Gastrointestinal stimulation, or pacing, was advocated as a possible treatment for gastric motor dysfunction as early as 1963. Experimentation in the late 1960s and early 1970s, began to demonstrate the significance of gastrointestinal myoelectrical activity and its
Rehydration drink
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
1.Field of the Invention
The present invention relates to a new liquid composition, a method for producing this composition and the use of this composition as rehydration drink.
2.Description of the Related Art
There are a number of liquid compositions or diluted mixtures
Protein free formula
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
The present invention relates to the stimulation of health in infants receiving an amino acid based formula.
BACKGROUND OF THE INVENTION
In a preferred situation, infants are breastfed by the mother. However, often in infants, after an initial period of being breast fed,
Benzimidazolone derivatives as CB2 receptor ligands
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
This invention relates to benzimidazolone derivatives. These compounds have selective cannabinoid(CB)2 receptor binding activity. The present invention also relates to a pharmaceutical composition, method of treatment and use, comprising the above derivatives for the
Sulfonyl benzimidazole derivatives
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
This invention relates to sulfonyl benzimidazole derivatives. These compounds have selective cannabinoid (CB)2 receptor agonistic activity. The present invention also relates to a pharmaceutical composition, method of treatment and use, comprising the above derivatives
Pharmaceutical preparations comprising substituted beta-aminoalcohols
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
The present invention relates to pharmaceutical preparations containing substituted aminoalcohols and to the use of substituted aminoalcohols for the production of pharmaceutical preparations and to substituted 2-(aminomethyl)cycloalkan-1-ol compounds and processes for
Saccharide compositions and method of use
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND
There is a constant need in the pharmaceutical industry for improvements on formulations that enable enhanced healing or evaluations of clinical syndromes involving ulceration of epithelium, whether on mucosal surfaces or on epidermal surfaces. The primary improvement of previously
Medical container with electrolyte solution stored therein
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
(a) Field of the Invention
This invention relates to a medical container with an electrolyte stored therein, and more specifically to a medical container which stores therein a body fluid replenisher to be administered through a peripheral vein or a central vein, such as
Den mest komplette databasen med medisinske urter støttet av vitenskap
- Fungerer på 55 språk
- Urtekurer støttet av vitenskap
- Urtegjenkjenning etter bilde
- Interaktivt GPS-kart - merk urter på stedet (kommer snart)
- Les vitenskapelige publikasjoner relatert til søket ditt
- Søk medisinske urter etter deres effekter
- Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter
Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot.
* All informasjon er basert på publisert vitenskapelig forskning
